Issue: March 2017, Posted Date: 3/15/2017

Avomeen Analytical Services Announces New CEO

Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named its CEO. High Street Capital of Chicago and Avomeen founder and retiring CEO Shri Thanedar, PhD, made the announcement.


Harvill will lead Avomeen’s day-to-day activities with an emphasis on continuing the company’s rapid growth achieved since its inception in 2010. High Street Capital is the majority shareholder of Avomeen following the company’s recapitalization at year-end 2016. Dr. Thanedar will continue to hold a minority interest and serve on the company’s Board of Directors. He will work closely with Harvill to ensure a smooth transition.


“Over the years, Avomeen has established itself as the go-to manufacturing problem-solving company, achieving great success under Shri’s leadership,” said Rob France, Principal of High Street Capital. “We are pleased to welcome Mark aboard to execute the next steps in Avomeen’s progression as a national leader in the custom product research & development space, and we look forward to reaching new heights as we pursue our aggressive growth goals in the years ahead.” 


A native Michigander, Harvill has more than 20 years of experience in contract research organization management, most recently serving as the Chief Operating Officer of Clinipace Worldwide in Morrisville, NC. There he was responsible for leading global operations in North America, Latin America, Europe, and Asia Pacific. Prior to Clinipace Harvill served as President and Chief Operating Officer of Paragon Biomedical in Irvine, CA. He also spent 12 years at STATPROBE in Ann Arbor as Executive Vice President.


“Avomeen is a thriving company, and I am excited to bring my knowledge and expertise in this industry to Ann Arbor,” Harvill said. “I’m proud to return to my home state of Michigan during a time of resurgence throughout the state, with the opportunity to guide Avomeen’s dedicated chemists and formulation developers to even greater success in product testing, development, and analytical problem solving.”


Founded in December 2010, Avomeen has asserted itself as a leader of a wide range of services related to laboratory testing and analysis in the pharmaceutical, medical device, polymer, cosmetic, consumer products, health & beauty, and manufacturing industries. The company is recognized as an industry expert in deformulation, a form of reverse engineering involving the separation, identification, and quantitation of both the major and minor ingredients in complex formulations, which is typically used to either troubleshoot or replicate and modify existing products.


Avomeen Analytical Services is a fast-growing analytical services and product development company serving multiple industries. Avomeen has five primary divisions, including manufacturing problem solving, product reverse engineering, custom product development, pharmaceutical development and chemical analysis for litigation. Avomeen has been an Inc. 5000 company 2 years in a row, a 2017 North American Growth Excellence Leadership of the Year Award recipient for Pharmaceutical Analytical Testing Services by Frost & Sullivan, and was named in the Top 50 Michigan Companies to Watch by Michigan Celebrates Small Business. For more information, visit

Related Taxonomy
This record has been viewed 541 times.


Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions